Synthesis and cytotoxicity of some rigid derivatives of methyl 2,5-dihydroxycinnamate

被引:8
作者
Nam, NH
Kim, Y
You, YJ
Hong, DH
Kim, HM
Ahn, BZ [1 ]
机构
[1] Chungnam Natl Univ, Coll Pharm, Taejon 305764, South Korea
[2] Res Inst Biosci & Biotechnol, Taejon 305600, South Korea
关键词
structure-activity relationship; cytotoxicity; cyclopentenone;
D O I
10.1007/BF02976927
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Eight rigid compounds designed as esterase-stable analogues of methyl 2,5-dihydroxycinnamate (1) were synthesized. These derivatives include 2-(2',5'-dihydroxybenzylidene)cyclopentenone (3a), 2-(2',5'-dihydroxybenzylidene)cyclohexanone (3b), 2,6-bis(2',5'-dihydroxybenzylidene)cyclohexanone (4b), 2,6-bis(2',5'-dihydroxybenzylidene)cyclopentenone (4a), (E)-3-(2',5'-dihydroxybenzylidene)pyrrolidin-2-one (5), (E)-5-(2',5'-dihydroxybenzylidene)-1,2-isothiazolidine-1,1-dioxide (6), 4-(2',5'-dihydroxyphenyl)-5H-furan-2-one (7), and 3-(2',5'-dihydroxyphenyl)cyclopent-2-ene-1-one (8). Among the eight compounds, the furanone 7 and cyclopentenone 8 showed the most potent cytotoxicity with IC50 values of 0.39-0.98 mug/mL. Compound 8 was further brominated, phenylated and methylated at the a position to give three corresponding analogues, including 2-bromo-3-(2',5'-dihydroxyphenyl)cyclopent-2-ene-1-one (24), 3-(2',5'-dihydroxyphenyl)-2-phenylcyclopent-2-ene-1-one (27), and 3-(2',5'-dihydroxyphenyl)-2-methylcyclopent-2-ene-1-one (28). Among the three, the most enhanced activity was observed with the phenylated compound 27.
引用
收藏
页码:590 / 599
页数:10
相关论文
共 19 条
[1]   DEGRADATION AND INACTIVATION OF ANTITUMOR DRUGS [J].
BENVENUTO, JA ;
CONNOR, TH ;
MONTEITH, DK ;
LAIDLAW, JL ;
ADAMS, SC ;
MATNEY, TS ;
THEISS, JC .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1993, 82 (10) :988-991
[2]   ANTICONVULSANT ACTIVITIES OF SOME ARYLSEMICARBAZONES DISPLAYING POTENT ORAL ACTIVITY IN THE MAXIMAL ELECTROSHOCK SCREEN IN RATS ACCOMPANIED BY HIGH PROTECTION INDEXES [J].
DIMMOCK, JR ;
SIDHU, KK ;
THAYER, RS ;
MACK, P ;
DUFFY, MJ ;
REID, RS ;
QUAIL, JW ;
PUGAZHENTHI, U ;
ONG, A ;
BIKKER, JA ;
WEAVER, DF .
JOURNAL OF MEDICINAL CHEMISTRY, 1993, 36 (16) :2243-2252
[3]   Conformational and quantitative structure-activity relationship study of cytotoxic 2-arylidenebenzocycloalkanones [J].
Dimmock, JR ;
Kandepu, NM ;
Nazarali, AJ ;
Kowalchuk, TP ;
Motaganahalli, N ;
Quail, JW ;
Mykytiuk, PA ;
Audette, GF ;
Prasad, L ;
Perjési, P ;
Allen, TM ;
Santos, CL ;
Szydlowski, J ;
De Clercq, E ;
Balzarini, J .
JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (08) :1358-1366
[4]   EVALUATION OF 2-BENZYLIDENECYCLOHEXANONES AND 2,6-BIS(BENZYLIDENE)CYCLOHEXANONES FOR ANTITUMOR AND CYTOTOXIC ACTIVITY AND AS INHIBITORS OF MITOCHONDRIAL-FUNCTION IN YEAST - METABOLISM STUDIES OF (E)-2-BENZYLIDENECYCLOHEXANONE [J].
DIMMOCK, JR ;
HAMON, NW ;
HINDMARSH, KW ;
SELLAR, AP ;
TURNER, WA ;
RANK, GH ;
ROBERTSON, AJ .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1976, 65 (04) :538-543
[5]   EVALUATION OF SOME MANNICH-BASES DERIVED FROM SUBSTITUTED ACETOPHENONES AGAINST P-388 LYMPHOCYTIC-LEUKEMIA AND ON RESPIRATION IN ISOLATED RAT-LIVER MITOCHONDRIA [J].
DIMMOCK, JR ;
SHYAM, K ;
HAMON, NW ;
LOGAN, BM ;
RAGHAVAN, SK ;
HARWOOD, DJ ;
SMITH, PJ .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1983, 72 (08) :887-894
[6]   STEREOCHEMISTRY OF 2-BENZALCYCLOHEXANONES + 2-BENZALCYCLOPENTANONES [J].
HASSNER, A ;
MEAD, TC .
TETRAHEDRON, 1964, 20 (10) :2201-&
[7]   2-[N1-2-pyrimidyl-aminobenzenesulfonamido] ethyl 4-bis(2-chloroethyl) aminophenyl butyrate:: A potent antitumor agent [J].
Huang, ZH ;
Yang, GJ ;
Lin, ZL ;
Huang, JL .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2001, 11 (09) :1099-1103
[8]   CYCLOOXYGENASE-2 INHIBITORS - SYNTHESIS AND PHARMACOLOGICAL ACTIVITIES OF 5-METHANESULFONAMIDO-1-INDANONE DERIVATIVES [J].
LI, CS ;
BLACK, WC ;
CHAN, CC ;
FORDHUTCHINSON, AW ;
GAUTHIER, JY ;
GORDON, R ;
GUAY, D ;
KARGMAN, S ;
LAU, CK ;
MANCINI, J ;
OUIMET, N ;
ROY, P ;
VICKERS, P ;
WONG, E ;
YOUNG, RN ;
ZAMBONI, R ;
PRASIT, P .
JOURNAL OF MEDICINAL CHEMISTRY, 1995, 38 (25) :4897-4905
[9]  
MICHELL JB, 1987, BR J CANC S8, V55, P96
[10]  
NAM MH, 2002, IN PRESS ARCH PHARM